Cabazitaxel Plus Prednisone (CBZP) in Metastatic Castration-Resistant Prostate Cancer (MCRPC) Patients Previously Treated with Docetaxel (D): Efficacy and Safety Results from Early-Access Program (EAP) Single Site Experience

Early Access ◽

Castration Resistant ◽

Previously Treated ◽

Changes in alkaline phosphatase (ALP) dynamics and overall survival (OS) in metastatic castration-resistant prostate cancer (mCRPC) patients treated with radium-223 in an international early access program (EAP)

Annals of Oncology ◽

10.1093/annonc/mdw372.35 ◽

2016 ◽

Vol 27 ◽

pp. vi255 ◽

Cited By ~ 2

Author(s):

D. Heinrich ◽

S. Gillessen ◽

A. Heidenreich ◽

D. Keizman ◽

J.M. O'Sullivan ◽

...

Keyword(s):

Prostate Cancer ◽

Overall Survival ◽

Alkaline Phosphatase ◽

Early Access ◽

Castration Resistant ◽

Radium 223 ◽

Changes in alkaline phosphatase (ALP) dynamics and overall survival (OS) in metastatic castration-resistant prostate cancer (mCRPC) patients treated with radium-223 in an international early access program (EAP)

Annals of Oncology ◽

10.1093/annonc/mdx423.007 ◽

2017 ◽

Vol 28 ◽

pp. vi19 ◽

Cited By ~ 1

Author(s):

G. Procopio ◽

G. Paganelli ◽

M. Cabria ◽

E. Cortesi ◽

M. Tucci ◽

...

Keyword(s):

Prostate Cancer ◽

Overall Survival ◽

Alkaline Phosphatase ◽

Early Access ◽

Castration Resistant ◽

Radium 223 ◽

Real-world cabazitaxel safety: the Italian early-access program in metastatic castration-resistant prostate cancer

Future Oncology ◽

10.2217/fon.13.256 ◽

2014 ◽

Vol 10 (6) ◽

pp. 975-983 ◽

Cited By ~ 31

Author(s):

Sergio Bracarda ◽

Angela Gernone ◽

Donatello Gasparro ◽

Paolo Marchetti ◽

Monica Ronzoni ◽

...

Keyword(s):

Prostate Cancer ◽

Real World ◽

Early Access ◽

Castration Resistant ◽

Radium-223 (Ra-223) Therapy after Abiraterone: Analysis of Symptomatic Skeletal Events (SSEs) in an International Early Access Program (iEAP) in Patients with Metastatic castration-Resistant Prostate Cancer (mCRPC)

Journal of Medical Imaging and Radiation Sciences ◽

10.1016/j.jmir.2019.03.122 ◽

2019 ◽

Vol 50 (1) ◽

pp. S40

Author(s):

Joe M. O’sullivan ◽

Kurt Miller ◽

Daniel Heinrich ◽

Joan Carles ◽

Manfred Wirth ◽

...

Keyword(s):

Prostate Cancer ◽

Early Access ◽

Castration Resistant ◽

Radium 223 ◽

Radium-223 with concomitant bone-targeting agents in metastatic castration-resistant prostate cancer (CRPC) patients treated in an international early access program (EAP)

Annals of Oncology ◽

10.1093/annonc/mdx423.006 ◽

2017 ◽

Vol 28 ◽

pp. vi18-vi19 ◽

Cited By ~ 1

Author(s):

G. Paganelli ◽

G. Procopio ◽

M. Cabria ◽

E. Cortesi ◽

M. Tucci ◽

...

Keyword(s):

Prostate Cancer ◽

Early Access ◽

Castration Resistant ◽

Bone Targeting ◽

Radium 223 ◽

Disease Characteristics and Completion of Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Radium-223 in an International Early Access Program

Clinical Genitourinary Cancer ◽

10.1016/j.clgc.2019.05.012 ◽

2019 ◽

Vol 17 (5) ◽

pp. 348-355.e5 ◽

Cited By ~ 6

Author(s):

Fred Saad ◽

Silke Gillessen ◽

Daniel Heinrich ◽

Daniel Keizman ◽

Joe M. O’Sullivan ◽

...

Keyword(s):

Prostate Cancer ◽

Early Access ◽

Castration Resistant ◽

Disease Characteristics ◽

Radium 223 ◽

Radium-223 with concomitant bone-targeting agents in metastatic castration-resistant prostate cancer (CRPC) patients treated in an international early access program (EAP)

Annals of Oncology ◽

10.1093/annonc/mdw372.34 ◽

2016 ◽

Vol 27 ◽

pp. vi254

Author(s):

F. Saad ◽

A. Heidenreich ◽

D. Heinrich ◽

D. Keizman ◽

J.M. O'Sullivan ◽

...

Keyword(s):

Prostate Cancer ◽

Early Access ◽

Castration Resistant ◽

Bone Targeting ◽

Radium 223 ◽

Radium-223 (Ra-223) in sequence or in concurrent use with abiraterone acetate (AA) or enzalutamide (E) in metastatic castration resistant prostate cancer (mCRPC) patients treated in an international early access program (iEAP)

European Urology Supplements ◽

10.1016/s1569-9056(17)30124-0 ◽

2017 ◽

Vol 16 (3) ◽

pp. e93-e94 ◽

Cited By ~ 3

Author(s):

F. Saad ◽

D. Heinrich ◽

S. Gillessen ◽

J. O’Sullivan ◽

J. Carles ◽

...

Keyword(s):

Prostate Cancer ◽

Abiraterone Acetate ◽

Early Access ◽

Castration Resistant ◽

Radium 223 ◽

Concurrent Use ◽

Radium-223 in an international early access program (EAP): Effects of concomitant medication on overall survival in metastatic castration-resistant prostate cancer (mCRCP) patients.

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.5034 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. 5034-5034 ◽

Cited By ~ 10

Author(s):

Fred Saad ◽

Joan Carles ◽

Silke Gillessen ◽

Daniel Heinrich ◽

Jeremy Gratt ◽

...

Keyword(s):

Prostate Cancer ◽

Overall Survival ◽

Concomitant Medication ◽

Early Access ◽

Castration Resistant ◽

Radium 223 ◽

Radium-223 (Ra-223) therapy after abiraterone (Abi): Analysis of symptomatic skeletal events (SSEs) in an international early access program (iEAP) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)

Annals of Oncology ◽

10.1093/annonc/mdy284.033 ◽

2018 ◽

Vol 29 ◽

pp. viii287 ◽

Cited By ~ 3

Author(s):

K. Miller ◽

D. Heinrich ◽

J.M. O’Sullivan ◽

J. Carles ◽

M. Wirth ◽

...

Keyword(s):

Prostate Cancer ◽

Early Access ◽

Castration Resistant ◽

Radium 223 ◽